Piera Gargiulo

1.3k total citations
26 papers, 393 citations indexed

About

Piera Gargiulo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Piera Gargiulo has authored 26 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Piera Gargiulo's work include Cancer Treatment and Pharmacology (6 papers), Cancer Genomics and Diagnostics (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Piera Gargiulo is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer Genomics and Diagnostics (6 papers) and Ovarian cancer diagnosis and treatment (5 papers). Piera Gargiulo collaborates with scholars based in Italy, Switzerland and United States. Piera Gargiulo's co-authors include Sandro Pignata, Chiara Della Pepa, Simona Berardi, Peter Brauchli, Marilena Di Napoli, Sabrina Chiara Cecere, Carmela Pisano, Stefania Scala, Luigi Buonaguro and Daniela Califano and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Piera Gargiulo

25 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Piera Gargiulo Italy	10	204	108	101	97	87	26	393
S. Loibl Germany	10	254 1.2×	227 2.1×	96 1.0×	93 1.0×	123 1.4×	30	516
Jennifer Veneris United States	11	250 1.2×	162 1.5×	73 0.7×	174 1.8×	73 0.8×	33	492
Valentina Tuninetti Italy	12	271 1.3×	117 1.1×	125 1.2×	186 1.9×	100 1.1×	28	600
Hualei Bu China	11	118 0.6×	102 0.9×	91 0.9×	173 1.8×	54 0.6×	24	354
Tomas Tanskanen Finland	14	167 0.8×	83 0.8×	109 1.1×	196 2.0×	67 0.8×	22	508
Alessandra Bologna Italy	12	288 1.4×	188 1.7×	62 0.6×	118 1.2×	74 0.9×	37	421
K. Oliva Australia	8	164 0.8×	46 0.4×	67 0.7×	120 1.2×	50 0.6×	13	431
Valentina Zanfagnin United States	12	182 0.9×	223 2.1×	54 0.5×	76 0.8×	47 0.5×	24	470
Nathalie L.G. Sieben Netherlands	8	108 0.5×	193 1.8×	131 1.3×	195 2.0×	50 0.6×	8	433
Yalun Li China	12	164 0.8×	44 0.4×	89 0.9×	117 1.2×	163 1.9×	39	412

Countries citing papers authored by Piera Gargiulo

Since Specialization

Citations

This map shows the geographic impact of Piera Gargiulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera Gargiulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera Gargiulo more than expected).

Fields of papers citing papers by Piera Gargiulo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera Gargiulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera Gargiulo. The network helps show where Piera Gargiulo may publish in the future.

Co-authorship network of co-authors of Piera Gargiulo

This figure shows the co-authorship network connecting the top 25 collaborators of Piera Gargiulo. A scholar is included among the top collaborators of Piera Gargiulo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera Gargiulo. Piera Gargiulo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arenare, Laura, Raimondo Di Liello, Pietro De Placido, et al.. (2024). Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trials. ESMO Open. 9(3). 102941–102941. 3 indexed citations

Marandino, Laura, Eleonora Ghisoni, Pasquale Lombardi, et al.. (2023). Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study. SHILAP Revista de lepidopterología. 2(1). e000021–e000021. 11 indexed citations

Rossi, Alessandro, Raimondo Di Liello, Piera Gargiulo, et al.. (2023). Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. European Journal of Cancer. 189. 112920–112920. 8 indexed citations

Leman, Raphaël, Étienne Muller, Nicolas Goardon, et al.. (2022). 2022-RA-935-ESGO Development of an academic genomic instability score for ovarian cancers. International Journal of Gynecological Cancer. 32. A280–A280. 1 indexed citations

Zichi, Clizia, Raimondo Di Liello, Piera Gargiulo, et al.. (2022). Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020. ESMO Open. 7(6). 100593–100593. 4 indexed citations

Perrone, Francesco, Raimondo Di Liello, Piera Gargiulo, et al.. (2021). The opportunity of patient-journey studies for academic clinical research in oncology. BMJ Open. 11(9). e052871–e052871. 3 indexed citations

Gargiulo, Piera, Laura Arenare, Cesare Gridelli, et al.. (2021). Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials. BMC Cancer. 21(1). 549–549. 8 indexed citations

Piccirillo, Maria Carmela, Laura Bonanno, Marina Chiara Garassino, et al.. (2021). 1207O Bevacizumab + erlotinib vs erlotinib alone as first-line treatment of pts with EGFR mutated advanced non squamous NSCLC: Final analysis of the multicenter, randomized, phase III BEVERLY trial. Annals of Oncology. 32. S950–S950. 8 indexed citations

Zichi, Clizia, Piera Gargiulo, Annapaola Mariniello, et al.. (2021). Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. European Journal of Cancer. 149. 49–60. 1 indexed citations

10.

Califano, Daniela, Daniela Russo, Giosuè Scognamiglio, et al.. (2020). Ovarian Cancer Translational Activity of the Multicenter Italian Trial in Ovarian Cancer (MITO) Group: Lessons Learned in 10 Years of Experience. Cells. 9(4). 903–903. 2 indexed citations

11.

Tazi, Youssef, Florian Heitz, Piera Gargiulo, et al.. (2020). LBA33 Maintenance olaparib plus bevacizumab (bev) in patients (pts) with newly diagnosed advanced high‐grade ovarian carcinoma (HGOC): Final analysis of second progression-free survival (PFS2) in the phase III PAOLA-1/ENGOT-ov25 trial. Annals of Oncology. 31. S1163–S1164. 13 indexed citations

12.

Curioni‐Fontecedro, Alessandra, Jean Yannis Perentes, Hans Gelpke, et al.. (2019). Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08). British Journal of Cancer. 120(10). 968–974. 5 indexed citations

13.

Stathis, Anastasios, Dagmar Hess, Roger von Moos, et al.. (2017). Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors. Investigational New Drugs. 35(6). 766–772. 29 indexed citations

14.

Bonotto, Marta, Lorenzo Gerratana, Massimo Di Maïo, et al.. (2016). Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. The Breast. 31. 114–120. 38 indexed citations

15.

Gargiulo, Piera, Chiara Della Pepa, Simona Berardi, et al.. (2016). Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?. Cancer Treatment Reviews. 48. 61–68. 93 indexed citations

16.

Gargiulo, Piera, Matilde Pensabene, Monica Milano, et al.. (2016). Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis. BMC Cancer. 16(1). 375–375. 32 indexed citations

17.

Bonotto, Marta, Lorenzo Gerratana, Grazia Arpino, et al.. (2015). First line treatment in patients with luminal-like metastatic breast cancer: a propensity score-matched analysis. Annals of Oncology. 26. vi8–vi8. 1 indexed citations

18.

Gargiulo, Piera, Laura Arenare, Carmela Pisano, et al.. (2015). Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer. Oncology. 90(1). 29–35. 16 indexed citations

19.

Perrone, Francesco, Francesco Nuzzo, Francesca Di Rella, et al.. (2014). Weekly Docetaxel (Wd) Vs Cmf As Adjuvant Chemotherapy for Elderly Early Breast Cancer (Ebc) Patients (Pts): Final Results from the Randomised Phase 3 Elda Trial. Annals of Oncology. 25. iv86–iv86. 1 indexed citations

20.

Pepa, Chiara Della, Giuseppe Tonini, Daniele Santini, et al.. (2014). Low Grade Serous Ovarian Carcinoma: From the molecular characterization to the best therapeutic strategy. Cancer Treatment Reviews. 41(2). 136–143. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact